Jennifer Ann Kanakry MD

Hematologic Oncology

Medical Director of Stem Cell Transplant and Cellular Immunotherapy Program

3800 Reservoir Rd WashingtonWashington, DC 20007

Dr. Kanakry is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kanakry's full profile Already have an account?

Education & Training

Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2010 - 2013
Johns Hopkins UniversityResidency, Internal Medicine, 2007 - 2010
Geisel School of Medicine at DartmouthClass of 2007

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

DC State Medical License 2025 - 2028
VA State Medical License 2025 - 2028
MD State Medical License 2010 - 2027
NJ State Medical License 2025 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014

Clinical Trials

Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors
TERMINATED
EARLY_PHASE1
Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies Start of enrollment: 2015 Nov 19
RECRUITING
PHASE2
Retrospective Study of Viral Reactivation Across All Bone Marrow Transplant Protocols Since 2010 Start of enrollment: 2017 Apr 13
COMPLETED

Publications & Presentations

PubMed

Absolute risk trade-offs of donor age, sex, and graft source in PTCy-based transplantation.
Yosra Aljawai, Mariam Nawas, Shannon McCurdy, Christopher G Kanakry, Jennifer A Kanakry
Blood Advances. 2026-07-28
Frequency, kinetics, and clinical significance of HHV-6 DNAemia after PTCy-based hematopoietic cell transplant.
Elisabetta Xue, Sanchita Das, Hyoyoung Choo-Wosoba, Dimana Dimitrova, Mustafa A Hyder
Blood Advances. 2026-07-17
Allogeneic hematopoietic cell transplantation for partial RAG deficiency in children and adults: Excellent outcomes with a reduced-intensity posttransplantation cyclop...
Dimana Dimitrova, Marita Bosticardo, Ottavia M Delmonte, Heather Kenney, Annie An
The Journal of Allergy and Clinical Immunology. 2026-07-01

Press Mentions

NCI's First Woman Senior ClinicianJuly 28th, 2022
First In Human DocuseriesJuly 12th, 2015

Grant Support

NIH Hematology Oncology Fellowship ProgramDIVISION OF BASIC SCIENCES - NCIPresent
Reduced toxicity allogeneic hematopoietic cell transplantation in malignanciesDIVISION OF BASIC SCIENCES - NCIPresent